Loading...

Siba P Raychaudhuri

TitleAssoc Prof
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Karlapudi V, Prasad Mungara AVV, Sengupta K, Davis BA, Raychaudhuri S. A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee. J Med Food. 2018 May; 21(5):511-520. PMID: 29708818.
      View in: PubMed
    2. Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri S, Jialal I. Correction to: Inflammation, Atherosclerosis, and Psoriasis. Clin Rev Allergy Immunol. 2018 Mar 19. PMID: 29557054.
      View in: PubMed
    3. Abdelhafez YG, Hagge RJ, Badawi RD, Raychaudhuri S, Chaudhari AJ. Early and Delayed 99mTc-MDP SPECT/CT Findings in Rheumatoid Arthritis and Osteoarthritis. Clin Nucl Med. 2017 Nov; 42(11):e480-e481. PMID: 28872556.
      View in: PubMed
    4. Raychaudhuri SK, Raychaudhuri S. Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis. Curr Opin Rheumatol. 2017 Jul; 29(4):311-316. PMID: 28394822.
      View in: PubMed
    5. Patel F, Wilken R, Patel FB, Sultani H, Bustos I, Duong C, Zone JJ, Raychaudhuri S, Maverakis E. Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture. Indian J Dermatol. 2017 May-Jun; 62(3):262-267. PMID: 28584368.
      View in: PubMed
    6. Raychaudhuri SP, Raychaudhuri S. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Res Ther. 2017 Mar 08; 19(1):51. PMID: 28270233.
      View in: PubMed
    7. Raychaudhuri SK, Abria C, Raychaudhuri S. Regulatory role of the JAK STAT kinase signalling system on the IL-23/IL-17 cytokine axis in psoriatic arthritis. Ann Rheum Dis. 2017 Oct; 76(10):e36. PMID: 28179265.
      View in: PubMed
    8. Raychaudhuri SK, Abria C, Raychaudhuri S. Functional Significance of Interleukin-9 and Its Receptor System in the Pathogenesis of Psoriatic Arthritis: Comment on the Article by Ciccia et al. Arthritis Rheumatol. 2017 Feb; 69(2):472-473. PMID: 27768837.
      View in: PubMed
    9. Raychaudhuri SP, Wilken R, Sukhov AC, Raychaudhuri S, Maverakis E. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. J Autoimmun. 2017 Jan; 76:21-37. PMID: 27836567.
      View in: PubMed
    10. Chaudhari AJ, Ferrero A, Godinez F, Yang K, Shelton DK, Hunter JC, Naguwa SM, Boone JM, Raychaudhuri S, Badawi RD. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study. Br J Radiol. 2016 Jul; 89(1063):20160138. PMID: 27109738.
      View in: PubMed
    11. Raychaudhuri SP, Raychaudhuri S. IL-23/IL-17 axis in spondyloarthritis-bench to bedside. Clin Rheumatol. 2016 Jun; 35(6):1437-41. PMID: 27075462.
      View in: PubMed
    12. Raychaudhuri SK, Wulff H, Raychaudhuri S. KCa3.1(-/-) Mice Do Not Develop CIA: Regulatory Role for KCa3.1 in Autoimmune Arthritis. J Cell Physiol. 2016 Nov; 231(11):2313-4. PMID: 26910182.
      View in: PubMed
    13. Kundu-Raychaudhuri S, Abria C, Raychaudhuri S. IL-9, a local growth factor for synovial T cells in inflammatory arthritis. Cytokine. 2016 Mar; 79:45-51. PMID: 26751012.
      View in: PubMed
    14. Mitra A, Luna JI, Marusina AI, Merleev A, Kundu-Raychaudhuri S, Fiorentino D, Raychaudhuri S, Maverakis E. Dual mTOR Inhibition Is Required to Prevent TGF-ß-Mediated Fibrosis: Implications for Scleroderma. J Invest Dermatol. 2015 Nov; 135(11):2873-2876. PMID: 26134944; PMCID: PMC4640976.
    15. Islam AD, Selmi C, Datta-Mitra A, Sonu R, Chen M, Gershwin ME, Raychaudhuri S. The changing faces of IgG4-related disease: Clinical manifestations and pathogenesis. Autoimmun Rev. 2015 Oct; 14(10):914-22. PMID: 26112170.
      View in: PubMed
    16. Raychaudhuri SK, Saxena A, Raychaudhuri S. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis. Clin Rheumatol. 2015 Jun; 34(6):1019-23. PMID: 25939522.
      View in: PubMed
    17. Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri S, Garcia MS, Maverakis E. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol. 2015 May; 95(5):525-31. PMID: 25387526.
      View in: PubMed
    18. Datta-Mitra A, Kundu-Raychaudhuri S, Mitra A, Raychaudhuri S. Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome. PLoS One. 2015; 10(4):e0121626. PMID: 25876154; PMCID: PMC4398317.
    19. Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J Autoimmun. 2015 Feb; 57:1-13. PMID: 25578468; PMCID: PMC4340844.
    20. Machado PM, Raychaudhuri S. Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2014 Oct; 28(5):711-28. PMID: 25488780.
      View in: PubMed
    21. Datta-Mitra A, Riar NK, Raychaudhuri S. Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer. Indian J Dermatol. 2014 Nov; 59(6):632. PMID: 25484418; PMCID: PMC4248526.
    22. Ogdie A, Schwartzman S, Eder L, Maharaj AB, Zisman D, Raychaudhuri S, Reddy SM, Husni E. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations. J Rheumatol. 2014 Nov; 41(11):2315-22. PMID: 25362717.
      View in: PubMed
    23. Deodhar A, Reveille JD, van den Bosch F, Braun J, Burgos-Vargas R, Caplan L, Clegg DO, Colbert RA, Gensler LS, van der Heijde D, van der Horst-Bruinsma IE, Inman RD, Maksymowych WP, Mease PJ, Raychaudhuri S, Reimold A, Rudwaleit M, Sieper J, Weisman MH, Landewé RB. The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns. Arthritis Rheumatol. 2014 Oct; 66(10):2649-56. PMID: 25154344.
      View in: PubMed
    24. Kundu-Raychaudhuri S, Chen YJ, Wulff H, Raychaudhuri S. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model. J Autoimmun. 2014 Dec; 55:63-72. PMID: 25175978; PMCID: PMC4398058.
    25. Kundu-Raychaudhuri S, Mitra A, Datta-Mitra A, Chaudhari AJ, Raychaudhuri S. In vivo quantification of mouse autoimmune arthritis by PET/CT. Int J Rheum Dis. 2016 May; 19(5):452-8. PMID: 24965561; PMCID: PMC4277495 [Available on 05/01/17].
    26. Raychaudhuri SP, Raychaudhuri S. The blue nails of argyria. Int J Dermatol. 2014 Sep; 53(9):e400-1. PMID: 24961661.
      View in: PubMed
    27. Kundu-Raychaudhuri S, Datta-Mitra A, Abria CJ, Peters J, Raychaudhuri S. Severe combined immunodeficiency mouse-psoriatic human skin xenograft model: a modern tool connecting bench to bedside. Indian J Dermatol Venereol Leprol. 2014 May-Jun; 80(3):204-13. PMID: 24823397.
      View in: PubMed
    28. Raychaudhuri S, Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun. 2014 Feb-Mar; 48-49:128-33. PMID: 24534717.
      View in: PubMed
    29. Raychaudhuri SK, Maverakis E, Raychaudhuri S. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014 Apr-May; 13(4-5):490-5. PMID: 24434359.
      View in: PubMed
    30. Raychaudhuri SK, Raychaudhuri S. mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target. Indian J Dermatol. 2014 Jan; 59(1):67-70. PMID: 24470663; PMCID: PMC3884931.
    31. Datta-Mitra A, Mitra A, Ray R, Raychaudhuri SP, Kundu-Raychaudhuri S. 1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade. Int Immunopharmacol. 2013 Nov; 17(3):744-51. PMID: 24036370.
      View in: PubMed
    32. Sivamani RK, Goodarzi H, Garcia MS, Raychaudhuri S, Wehrli LN, Ono Y, Maverakis E. Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clin Rev Allergy Immunol. 2013 Apr; 44(2):121-40. PMID: 22311162.
      View in: PubMed
    33. Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri S, Jialal I. Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol. 2013 Apr; 44(2):194-204. PMID: 22359071.
      View in: PubMed
    34. Raychaudhuri S. A cutting edge overview: psoriatic disease. Clin Rev Allergy Immunol. 2013 Apr; 44(2):109-13. PMID: 22359072.
      View in: PubMed
    35. Raychaudhuri S. Role of IL-17 in psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol. 2013 Apr; 44(2):183-93. PMID: 22362575.
      View in: PubMed
    36. Datta Mitra A, Raychaudhuri SP, Abria CJ, Mitra A, Wright R, Ray R, Kundu-Raychaudhuri S. 1a,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol. 2013 Jun; 133(6):1556-64. PMID: 23314787.
      View in: PubMed
    37. Nguyen CT, Raychaudhuri S. Authors' reply. Indian J Dermatol. 2013 Jan; 58(1):81. PMID: 23372224; PMCID: PMC3555385.
    38. Raychaudhuri S, Mitra A. Polymyositis and dermatomyositis: Disease spectrum and classification. Indian J Dermatol. 2012 Sep; 57(5):366-70. PMID: 23112356; PMCID: PMC3482799.
    39. Mitra A, Raychaudhuri SK, Raychaudhuri S. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade. Cytokine. 2012 Oct; 60(1):38-42. PMID: 22840496.
      View in: PubMed
    40. Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri S, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K, Walsh JA. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis. 2013 Jun; 72(6):986-91. PMID: 22798567.
      View in: PubMed
    41. Mitra A, Raychaudhuri SK, Raychaudhuri S. Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther. 2012 Mar 14; 14(2):R65. PMID: 22417743; PMCID: PMC3446433.
    42. Raychaudhuri S. Comorbidities of psoriatic arthritis -- metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012 Feb; 39(2):437-40. PMID: 22298276.
      View in: PubMed
    43. Raychaudhuri SP, Raychaudhuri S, Atkuri KR, Herzenberg LA, Herzenberg LA. Nerve growth factor: A key local regulator in the pathogenesis of inflammatory arthritis. Arthritis Rheum. 2011 Nov; 63(11):3243-52. PMID: 21792838.
      View in: PubMed
    44. Ratnarathorn M, Raychaudhuri S, Naguwa S. Disseminated granuloma annulare: a cutaneous adverse effect of anti-tnf agents. Indian J Dermatol. 2011 Nov; 56(6):752-4. PMID: 22345789; PMCID: PMC3276915.
    45. Vishal AA, Mishra A, Raychaudhuri S. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee. Int J Med Sci. 2011; 8(7):615-22. PMID: 22022214; PMCID: PMC3198257.
    46. Raychaudhuri SP, Raychaudhuri S, Genovese MC. IL-17 receptor and its functional significance in psoriatic arthritis. Mol Cell Biochem. 2012 Jan; 359(1-2):419-29. PMID: 21894442.
      View in: PubMed
    47. Saxena A, Raychaudhuri SK, Raychaudhuri S. Interleukin-17-induced proliferation of fibroblast-like synovial cells is mTOR dependent. Arthritis Rheum. 2011 May; 63(5):1465-6. PMID: 21305532.
      View in: PubMed
    48. Sengupta K, Kolla JN, Krishnaraju AV, Yalamanchili N, Rao CV, Golakoti T, Raychaudhuri S, Raychaudhuri S. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract. Mol Cell Biochem. 2011 Aug; 354(1-2):189-97. PMID: 21479939.
      View in: PubMed
    49. Nguyen CT, Raychaudhuri S. SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFa THERAPY. Indian J Dermatol. 2011 Jan; 56(1):82-3. PMID: 21572800; PMCID: PMC3088944.
    50. Weisman M, Learch TJ, Baraliakos X, Chandran V, Gladman DD, Raychaudhuri S, Xu H, Collantes-Estévez E, Vázquez-Mellado J, Mease PJ, Sieper J, Deodhar AA, Colbert RA, Clegg DO. Current controversies in spondyloarthritis: SPARTAN. J Rheumatol. 2010 Dec; 37(12):2617-23. PMID: 21123334.
      View in: PubMed
    51. Mittal M, Raychaudhuri S. Golimumab and certolizumab: the two new anti-tumor necrosis factor kids on the block. Indian J Dermatol Venereol Leprol. 2010 Nov-Dec; 76(6):602-8; quiz 609. PMID: 21079302.
      View in: PubMed
    52. Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri S. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci. 2010 Nov 01; 7(6):366-77. PMID: 21060724; PMCID: PMC2974165.
    53. Raychaudhuri SK, Chatterjee S, Nguyen C, Kaur M, Jialal I, Raychaudhuri S. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord. 2010 Aug; 8(4):331-4. PMID: 20367239; PMCID: PMC3129701.
    54. Raychaudhuri SK, Raychaudhuri S. Functional significance of nerve growth factor and its receptor (TrkA) in inflammatory arthritis. Arthritis Res Ther. 2010; 12(3):404. PMID: 20609261; PMCID: PMC2911887.
    55. Raychaudhuri SK, Raychaudhuri S. Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases. Indian J Dermatol. 2010 Apr-Jun; 55(2):157-60. PMID: 20606886; PMCID: PMC2887521.
    56. Sivamani RK, Correa G, Ono Y, Bowen MP, Raychaudhuri S, Maverakis E. Biological therapy of psoriasis. Indian J Dermatol. 2010 Apr-Jun; 55(2):161-70. PMID: 20606887; PMCID: PMC2887522.
    57. Chandran V, Raychaudhuri S. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010 May; 34(3):J314-21. PMID: 20034760.
      View in: PubMed
    58. Crowley DC, Lau FC, Sharma P, Evans M, Guthrie N, Bagchi M, Bagchi D, Dey DK, Raychaudhuri S. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci. 2009 Oct 09; 6(6):312-21. PMID: 19847319; PMCID: PMC2764342.
    59. Raychaudhuri SK, Raychaudhuri S. NGF and its receptor system: a new dimension in the pathogenesis of psoriasis and psoriatic arthritis. Ann N Y Acad Sci. 2009 Sep; 1173:470-7. PMID: 19758188.
      View in: PubMed
    60. Raychaudhuri SP, Nguyen CT, Raychaudhuri S, Gershwin ME. Incidence and nature of infectious disease in patients treated with anti-TNF agents. Autoimmun Rev. 2009 Dec; 9(2):67-81. PMID: 19716440.
      View in: PubMed
    61. Raychaudhuri SP, Raychaudhuri S. Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases. Indian J Dermatol. 2009; 54(2):100-9. PMID: 20101303; PMCID: PMC2807147.
    62. Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri S. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008; 10(4):R85. PMID: 18667054; PMCID: PMC2575633.
    63. Raychaudhuri SP, Jiang WY, Raychaudhuri S. Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol. 2008 Apr; 172(4):961-71. PMID: 18349121; PMCID: PMC2276420.
    64. Raychaudhuri SP, Kundu-Raychaudhuri S, Tamura K, Masunaga T, Kubo K, Hanaoka K, Jiang WY, Herzenberg LA, Herzenberg LA. FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model. J Invest Dermatol. 2008 Aug; 128(8):1969-76. PMID: 18337836.
      View in: PubMed
    65. Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri S, Paus R, Pincelli C. Neurotrophins in skin biology and pathology. J Invest Dermatol. 2006 Aug; 126(8):1719-27. PMID: 16845411.
      View in: PubMed
    66. Raychaudhuri SP, Jiang WY, Raychaudhuri S, Krensky AM. Lesional T cells and dermal dendrocytes in psoriasis plaque express increased levels of granulysin. J Am Acad Dermatol. 2004 Dec; 51(6):1006-8. PMID: 15583601.
      View in: PubMed
    67. Raychaudhuri SP, Sanyal M, Weltman H, Kundu-Raychaudhuri S. K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol. 2004 Mar; 122(3):812-9. PMID: 15086569.
      View in: PubMed
    68. Raychaudhuri SP, Raychaudhuri S. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res. 2004; 146:433-7. PMID: 14699978.
      View in: PubMed
    69. Raychaudhuri SP, Navare T, Gross J, Raychaudhuri S. Clinical course of psoriasis during pregnancy. Int J Dermatol. 2003 Jul; 42(7):518-20. PMID: 12839599.
      View in: PubMed